Inogen (INGN) & The Competition Financial Survey

Inogen (NASDAQ:INGN) is one of 511 publicly-traded companies in the “Healthcare Equipment & Supplies” industry, but how does it weigh in compared to its peers? We will compare Inogen to similar businesses based on the strength of its earnings, analyst recommendations, profitability, institutional ownership, dividends, valuation and risk.

Valuation & Earnings

This table compares Inogen and its peers gross revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Net Income	Price/Earnings Ratio
Inogen	$348.67 million	-$22.75 million	-4.66
Inogen Competitors	$1.88 billion	$139.14 million	12.56

Inogen’s peers have higher revenue and earnings than Inogen. Inogen is trading at a lower price-to-earnings ratio than its peers, indicating that it is currently more affordable than other companies in its industry.

Institutional and Insider Ownership

89.9% of Inogen shares are owned by institutional investors. Comparatively, 40.6% of shares of all “Healthcare Equipment & Supplies” companies are owned by institutional investors. 2.5% of Inogen shares are owned by company insiders. Comparatively, 15.0% of shares of all “Healthcare Equipment & Supplies” companies are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Risk and Volatility

Inogen has a beta of 1.51, meaning that its share price is 51% more volatile than the S&P 500. Comparatively, Inogen’s peers have a beta of 2.57, meaning that their average share price is 157% more volatile than the S&P 500.

Analyst Ratings

This is a summary of recent recommendations and price targets for Inogen and its peers, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Inogen	1	0	0	1	2.50
Inogen Competitors	4284	10561	18340	830	2.46

As a group, “Healthcare Equipment & Supplies” companies have a potential upside of 20.26%. Given Inogen’s peers higher possible upside, analysts clearly believe Inogen has less favorable growth aspects than its peers.

Profitability

This table compares Inogen and its peers’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Inogen	-6.94%	-13.17%	-8.36%
Inogen Competitors	-276.78%	-149.08%	-21.73%

About Inogen

Inogen, Inc., a medical technology company, develops, manufactures, and markets portable oxygen concentrators to patients, physicians and other clinicians, and third-party payors in the United States and internationally. Its oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. The company offers Inogen One, a portable device that concentrate the air around the patient to provide a source of supplemental oxygen; Inogen At Home stationary oxygen concentrators; Simeox airway clearance; batteries; and related accessories. It also rents its products directly to patients. Inogen, Inc. was incorporated in 2001 and is headquartered in Goleta, California.